pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

2,507 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1786Endpoints1391Fierce Biotech710BioSpace702BioPharma Dive526raps234onclive165fda recalls
therapy area
allOncology12335Rare Disease3228Immunology2872Cardiology2752Hematology2179Pulmonology2149Vaccines
  • Amgen Announces Retirement of Chief Technology Officer David Reese
    Amgen announced that longtime leader David Reese will retire at the end of June. Reese, 63, currently serves as the company's chief technology officer, a position he created in 2023 after many yea…
    Endpoints · 6mo agoNeutral↗ source
  • AbbVie allocates $1.4 billion for new 185-acre manufacturing campus in Durham, NC
    AbbVie has disclosed more details of its $100 billion pledge to the United States, setting aside $1.4 billion to build its first manufacturing campus in North Carolina. The project will cover a 18…
    Endpoints · 6mo agoDealNeutral↗ source
← prev
page 101 of 101
next →
113
fda medwatch111
globenewswire health73
fda press59
1802
Psychiatry & CNS1204
Ophthalmology1062
Pain778
Endocrinology & Metabolism777
Nephrology762
  • OpenAI releases free ChatGPT for Clinicians to assist doctors, nurses and pharmacists
    OpenAI announced the launch of ChatGPT for Clinicians, a free AI‑powered tool designed for use by physicians, nurse practitioners, physician assistants and pharmacists. The service aims to help cl…
    Endpoints · 6mo agoPositive↗ source
  • BridgeBio Oncology appoints CSO Pedro Beltran as CEO, makes Neil Kumar executive chairman
    BridgeBio Oncology Therapeutics announced a leadership reshuffle aimed at strengthening its focus on KRAS-driven cancer programs. The company is replacing CEO Eli Wallace with its chief scientific…
    Endpoints · 6mo agoNeutral↗ source
  • Pharma-backed petition urges FDA to change policy on public release of drug rejection letters
    A law firm representing an unnamed pharmaceutical company has filed a petition asking the FDA to revise its new practice of publishing partially redacted drug rejection letters. The petition argue…
    Endpoints · 6mo agoRegulatoryNegative↗ source
  • Biotech layoff tracker 2026 shows Clinuvel cuts 20% staff, Novartis sheds 322 US jobs
    Fierce Biotech released its fifth annual layoff tracker for 2026, noting that workforce reductions continue to rise in the sector after a year of increasing cuts. The July update lists two compani…
    Fierce Biotech · 10mo agoLayoffsNegative↗ source
  • Biotech fundraising tracker reports $70M Series C for Ratio Therapeutics and $130M Series B for Crystalys Therapeutics
    The Fierce Biotech Fundraising Tracker continues to log only large venture capital rounds, focusing on deals of $50 million or more. Ratio Therapeutics secured a $70 million Series C, backed by in…
    Fierce Biotech · 10mo agoDealNeutral↗ source